about
The role of oxidative stress in Parkinson's diseaseThe role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelismMetabolic disturbances in diseases with neurological involvementTetraspanin (TSP-17) protects dopaminergic neurons against 6-OHDA-induced neurodegeneration in C. elegansOxidative polymorphism of debrisoquine in Parkinson's diseaseConsiderations on the role of environmental toxins in idiopathic Parkinson's disease pathophysiologyThe relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's diseaseCurrent theories on the cause of Parkinson's diseaseBrain mitochondria from DJ-1 knockout mice show increased respiration-dependent hydrogen peroxide consumption.Critical role of truncated α-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease.Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrationIdiopathic Parkinson's disease: epidemiology, diagnosis and management.Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells.ABC of nutrition. Reducing the risk of coronary heart disease.Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases.L-dopa reverses behavioral deficits in the Pitx3 mouse fetusImpact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease.Activation of MAPK and FoxO by manganese (Mn) in rat neonatal primary astrocyte cultures.The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.Dopaminergic toxicity of the herbicide atrazine in rat striatal slicesAging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism.Susceptibility to a parkinsonian toxin varies during primate developmentAgeing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates.A novel use of combined tyrosine hydroxylase and silver nucleolar staining to determine the effects of a unilateral intrastriatal 6-hydroxydopamine lesion in the substantia nigra: a stereological study.Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: characterization and localization of receptor binding sites in rat and human brainAdenosine monophosphate-activated protein kinase overactivation leads to accumulation of α-synuclein oligomers and decrease of neurites.GLP-2 Attenuates LPS-Induced Inflammation in BV-2 Cells by Inhibiting ERK1/2, JNK1/2 and NF-κB Signaling Pathways.α-Synuclein oligomers and clinical implications for Parkinson disease.Calcium homeostasis, selective vulnerability and Parkinson's diseasePrenatal ontogeny of the dopamine-dependent neurobehavioral phenotype in Pitx3-deficient mice.How far are we in understanding the cause of Parkinson's disease?Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease.Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.Developmental heptachlor exposure increases susceptibility of dopamine neurons to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)in a gender-specific manner.L-dopa-responsive movement disorder caused by Nocardia asteroides localized in the brains of miceGlutathione deficiency in Gclm null mice results in complex I inhibition and dopamine depletion following paraquat administrationMicroglia enhance manganese chloride-induced dopaminergic neurodegeneration: role of free radical generationAlzheimer's disease and blood-brain barrier function-Why have anti-beta-amyloid therapies failed to prevent dementia progression?Preferentially increased nitration of alpha-synuclein at tyrosine-39 in a cellular oxidative model of Parkinson's disease.Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
P2860
Q24307946-48471F2B-5032-449D-B119-15DD53543FA0Q26852148-6918B643-8A10-456F-95A7-FCD3122EDB33Q26999015-D75FB35D-B4A4-47D5-9D6E-0472F18FCE1CQ28542478-A94584F0-348F-44E4-9190-C9418000AF44Q33588811-49665B5A-8E14-45C2-BA42-E0C804A1CE6FQ33603777-94DCE982-DC22-4367-B2CE-4606E106BA8AQ33631292-18919883-2FF1-4048-9354-7CD4B9D98A29Q33631680-89CBCC60-4CD3-4642-99D5-B4E9FB882169Q33737338-476E370A-0752-4BBB-8CA1-0673C6A48772Q33894382-C89F5373-8593-41EA-90CB-97BFA792488CQ34037199-884AB386-A0CD-41F9-84BB-11C13F37B3DEQ34053847-37F5B40D-6130-4AFC-BE68-987738AF23A5Q34367534-23B4B369-5771-4848-99E6-A6E8AA5A53B4Q34485761-04CBA15A-C83B-4409-A2BD-061F24A67210Q34905120-907C76C5-BAA6-47F6-B013-97565A2243B8Q35132221-54790FBC-ABED-4A0D-BC22-8DC14EE12C2BQ35147689-422309A7-53E1-4675-B2C9-C04907F7A054Q35160934-4A049B8B-EC21-4A00-9BA6-78608334FE9BQ35628604-B39AF0FE-FD87-4E0E-9FDE-2A30CC30D571Q35754193-7FD21C51-8F5D-4FB9-9F81-6F6746D390F3Q35856679-23F902FA-59F7-42C3-8B97-ADE8BB5E5068Q35907253-6F1B47BA-607E-4D79-8CEF-9D27F3F1DE20Q36070618-B9E89A0F-5F68-4462-9334-3ABB2974F3D0Q36236583-5D7FFA63-304C-4DBA-BCB9-76F2A1B6B7CEQ36273938-3AAA079C-ECE6-4ABF-BD92-F81238154C79Q36604979-C474D023-A816-4F3A-8BE2-315D5CABBA36Q36667043-1B145C2C-CD75-426C-9249-EB2C61D144EFQ36718306-B8390D36-6282-4AD3-90A2-F7DB2EC635FBQ36798264-0630BD93-05E5-4C07-A57A-944F2192426FQ36863946-C3FCEC77-0644-4AC4-96FB-3288EEE23AD6Q36893823-06D94A6A-154A-4CA2-8A03-16E7EC7DFD51Q36902693-01C55BC7-4FC2-469F-BF22-06CF1297E3E2Q36913723-8E7CEB7B-D91C-49B9-8CA0-86BB3305388FQ36952358-6D41C568-B29F-4B35-BC28-01B3EE964327Q36959373-FAF92432-D4C8-4826-8EF4-071A1FA736E3Q37000031-FE898006-7430-4220-9E0D-D4B55C339A40Q37169187-26BE21B7-961A-42F9-A9A4-F72376FF6AB2Q37253310-FE43F297-3629-4D7F-A623-8245B060C09FQ37357416-665B9800-EAA1-4D40-B641-02C5269D757EQ37599177-3ECAE365-DF4E-4E9D-B0D4-3BC14BF9309F
P2860
description
1983 nî lūn-bûn
@nan
1983 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Aetiology of Parkinson's disease
@ast
Aetiology of Parkinson's disease
@en
Aetiology of Parkinson's disease
@nl
type
label
Aetiology of Parkinson's disease
@ast
Aetiology of Parkinson's disease
@en
Aetiology of Parkinson's disease
@nl
prefLabel
Aetiology of Parkinson's disease
@ast
Aetiology of Parkinson's disease
@en
Aetiology of Parkinson's disease
@nl
P1433
P1476
Aetiology of Parkinson's disease
@en
P2093
J W Langston
P304
P407
P433
P577
1983-12-01T00:00:00Z